Moreover, AD patients harboring the R47H variant of TREM2 display higher levels of both total tau and phosphorylated tau (Thr181) in CSF compared to non-carriers, without any change in Aβ42 levels [102, 140]. Here, MAPT is linked to Alzheimer disease.